Appears that the Oppenheimer Funds are more than happy to continually buy shares in NIM/NAL. Before too long this will be held entirely in US hands...
-------------------------------------------------
Norwood Immunology - Holding(s) in Company
RNS Number:4584H
Norwood Immunology Ld
09 August 2006
SCHEDULE 10
NOTIFICATION OF MAJOR INTERESTS IN SHARES
1. Name of company
Norwood Immunology Limited
2. Name of shareholder having a major interest
Norwood Abbey Limited
3. Please state whether notification indicates that it is in respect of holding
of the shareholder named in 2 above or in respect of a non-beneficial interest
or in the case of an individual holder if it is a holding of that person's
spouse or children under the age of 18
Shareholder named above
4. Name of the registered holder(s) and, if more than one holder, the number of
shares held by each of them
Norwood Abbey Limited
5. Number of shares / amount of stock acquired
n/a
6. Percentage of issued class
n/a
7. Number of shares / amount of stock disposed
10,100,000
8. Percentage of issued class
8.2%
9. Class of security
Ordinary Shares
10. Date of transaction
8 August 2006
11. Date company informed
8 August 2006
12. Total holding following this notification
93,615,000
13. Total percentage holding of issued class following this notification
75.5%
14. Any additional information
n/a
15. Name of contact and telephone number for queries
Lisa Baderoon, Buchanan Communications 0207 466 5000
16. Name and signature of authorised company official responsible for making
this notification
Richard Scarrott
Date of notification
9 August 2006
Norwood Immunology - Holding(s) in Company
RNS Number:4949H
Norwood Immunology Ld
10 August 2006
SCHEDULE 10
NOTIFICATION OF MAJOR INTERESTS IN SHARES
1. Name of company
Norwood Immunology Limited
2. Name of shareholder having a major interest
OppenheimerFunds, Inc.
3. Please state whether notification indicates that it is in respect of holding
of the shareholder named in 2 above or in respect of a non-beneficial interest
or in the case of an individual holder if it is a holding of that person's
spouse or children under the age of 18
Shareholder named above
4. Name of the registered holder(s) and, if more than one holder, the number of
shares held by each of them
OppenheimerFunds, Inc.
5. Number of shares / amount of stock acquired
10,000,000
6. Percentage of issued class
8.1%
7. Number of shares / amount of stock disposed
n/a
8. Percentage of issued class
n/a
9. Class of security
Ordinary Shares
10. Date of transaction
8 August 2006
11. Date company informed
10 August 2006
12. Total holding following this notification
15,000,000
13. Total percentage holding of issued class following this notification
12.1%
14. Any additional information
n/a
15. Name of contact and telephone number for queries
Lisa Baderoon, Buchanan Communications 0207 466 5000
16. Name and signature of authorised company official responsible for making
this notification
Richard Scarrott
Date of notification
10 August 2006
The FSA does not give any express or implied warranty as to the accuracy of this
document or material and does not accept any liability for error or omission.
The FSA is not liable for any damages (including, without limitation, damages
for loss of business or loss of profits) arising in contract, tort or otherwise
from the use of or inability to use this document, or any material contained in
it, or from any action or decision taken as a result of using this document or
any such material.
This information is provided by RNS
The company news service from the London Stock Exchange
- Forums
- ASX - By Stock
- NAL
- oppenheimer funds
oppenheimer funds
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NAL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online